Here's What Ending the Medicare Drug Subsidy Really Means for Your Parents' Premiums in 2027

The Centers for Medicare and Medicaid Services (CMS) will stop cushioning prescription drug premiums after 2026, and nearly 25 million seniors could feel it in 2027. Whether their monthly bills rise or fall depends entirely on who is explaining it.

On Tuesday, CMS confirmed it will wind down the Part D Premium Stabilization Demonstration, a scheme that channelled billions of dollars to private insurers to hold down what older Americans pay for medication. Administration officials put this year's subsidy bill at roughly $3.6 billion (£2.7 billion). The striking part is how the same decision is being sold as both a saving and a hit.

The 'Bailout' Argument

CMS Administrator Dr Mehmet Oz cast the change as the end of a handout the market has outgrown. 'We are stabilizing the market so this bailout is no longer needed,' he wrote on X, adding that premiums would rise by less than $10 (£7.52) for most recipients and drop for many.

A Trump administration official pushed the logic further. Because the government absorbed much of the cost, the official argued, the subsidies gave insurers an incentive to lift their bids rather than restrain them. Remove the support, the reasoning goes, and the market prices itself honestly.

What Your Parents Will Actually Pay

Under the demonstration, plans received a direct federal subsidy and a cap on annual premium jumps, which kept many bills flat. Ending it removes both.

The base numbers tell a plainer story. The national base monthly premium climbs from $38.99 (£29.33) this year to $41.33 (£31.09) in 2027, a roughly 6% rise that matches the ceiling set by the Inflation Reduction Act through 2029.

That figure sits on top of real pressure. Insurers are swallowing higher bills for GLP-1 weight-loss drugs and other specialty medicines, expenses that were always going to test premiums once federal help thinned out.

The Number Buried in the Fine Print

Here is the detail that complicates the White House framing. Around 75% of standalone Part D enrollees are expected to see premiums increase next year, according to the Wall Street Journal, which first reported the move.

The Medicare Payment Advisory Commission, a federal watchdog, estimated the subsidy cut the average Part D premium by about 27% this year and roughly 40% in 2025. Pull that support away and much of the saving unwinds. The average plan ran about $36 (£27) a month this year, per health policy group KFF.

Why It Lands Before the Midterms

Timing sharpens everything. Seniors will not see their final 2027 rates until the autumn, only weeks before midterm elections in which the cost of healthcare is already a defining fight. Many of those enrollees live on fixed incomes, where even a small monthly rise can force trade-offs between medicine and other essentials.

Congressional Democrats branded the change a premium hike on more than 11 million Americans. CMS says other cost controls remain in place and that final figures, due in September, will show most people paying only a little more. The largest Part D insurers, including UnitedHealth Group, Humana, and CVS Health's Aetna, will set the plans that decide who is right.

For adult children helping parents manage medication budgets, the practical advice is narrow. Read the autumn rate letters carefully, because the number that counts is the one that arrives in the mailbox, not the one being argued over in Washington.